| Website | https://www.pequo... |
| Phone | 212.651.3400 |
| investor_relation... | |
| Employees | |
| Founded | 1988 |
Pequot Capital Management, Inc. is a U.S. registered investment adviser founded in 1998 by Arthur J. Samberg, Chairman and Chief Executive Officer, to manage the Pequot Family of Funds, which began trading in 1986. The firm manages approximately $5.0 billion in assets as of September 30, 2008 (including approximately $580 million of uncalled committed capital) in multiple strategies. An institutional quality infrastructure and an extensive proprietary research platform supports over 150 employees, with offices in Connecticut, New York, California and London.
Pequot Capital offers a diverse range of investment products tailored to the needs of domestic and offshore investors. Their clients include institutions and sophisticated high net worth investors. They continually evaluate their product line and encourage innovation within the firm.
| Company | Date | Round | Size | Participants |
| EnzymeRx | 5/08 | Venture Round | $14M | 1 |
| Range Fuels | 4/08 | Series C | $28.2M | 4 |
| Stemline Therapeutics | 4/08 | Series A | $12.5M | 1 |
| RealD | 1/08 | Series D | $20M | 1 |
| Paracor Medical | 6/07 | Series D | $44M | 8 |
| DiObex | 4/07 | Series B | $24M | 6 |
| MAP Pharmaceuticals | 3/07 | Series D | $50M | 6 |
| Sanarus Medical | 2/07 | Series E | $15M | 6 |
| Sadra Medical | 10/06 | Series B | $19M | 5 |
| Codexis | 8/06 | Series D | $37M | 5 |
| Facet Solutions | 12/05 | Series B | $16.5M | 3 |
| GCT Semiconductor | 11/05 | Series D | $20M | 9 |
| Sadra Medical | 6/04 | Series A | $9M | 3 |
| Blazent | 5/04 | Series C | $10M | 4 |
| Blazent | 3/03 | Series B | $9.2M | 5 |
| Blazent | 1/02 | Series A | $4.2M | 2 |
| Elance | 9/00 | Series B | $50M | 2 |
